Indivior is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. For more than 25 years, we have revolutionized the science of addiction medicine — developing treatments that help people move toward long-term recovery with independence and dignity.

Our commitment is unwavering: to expand access to effective treatment, dismantle stigma, and empower every person living with OUD to define their lives beyond the disease.